Antifungal Stewardship Programs in Children: Challenges and Opportunities

Affiliations

¹ From the 3rd Department Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, and Hippokration General Hospital, Thessaloniki, Greece.

Maria Kourti et al. Pediatr Infect Dis J. 2023.

. 2023 Jul 1;42(7):e246-e248.

doi: 10.1097/INF.0000000000003967. Epub 2023 May 30.

¹ From the 3rd Department Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, and Hippokration General Hospital, Thessaloniki, Greece.

No abstract available

Conflict of interest statement

The authors have no funding or conflicts of interest to disclose.

1. Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:e51–e77.
1. Eguiguren L, Newland J, Kronman M, et al. The current state of antifungal stewardship among pediatric antimicrobial stewardship programs. Infect Control Hosp Epidemiol. 2020;41:1279–1284.
1. Hamdy RF, Zaoutis TE, Seo SK. Antifungal stewardship considerations for adults and pediatrics. Virulence. 2017;8:658–672.
1. Santiago-García B, Rincón-López EM, Ponce Salas B, et al.; POPA Study Group. Effect of an intervention to improve the prescription of antifungals in pediatric hematology-oncology. Pediatr Blood Cancer. 2020;67:e27963.
1. Fisher BT, Robinson PD, Lehrnbecher T, et al. Risk factors for invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review. J Pediatric Infect Dis Soc. 2018;7:191–198.